Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis

The literature of the last 4 years confirms that the anti-CCP2 test is a very useful marker for the early and specific diagnosis of rheumatoid arthritis (RA). The anti-CCP2 test is very specific for RA (95–99%) and has sensitivity comparable to that of the rheumatoid factor (70–75%). The antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: van Venrooij, Walther J., Zendman, Albert J. W.
Formato: Texto
Lenguaje:English
Publicado: Humana Press Inc 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243253/
https://www.ncbi.nlm.nih.gov/pubmed/18270856
http://dx.doi.org/10.1007/s12016-007-8029-y
_version_ 1782150637692125184
author van Venrooij, Walther J.
Zendman, Albert J. W.
author_facet van Venrooij, Walther J.
Zendman, Albert J. W.
author_sort van Venrooij, Walther J.
collection PubMed
description The literature of the last 4 years confirms that the anti-CCP2 test is a very useful marker for the early and specific diagnosis of rheumatoid arthritis (RA). The anti-CCP2 test is very specific for RA (95–99%) and has sensitivity comparable to that of the rheumatoid factor (70–75%). The antibodies can be detected very early in the disease and can be used as an indicator for the progression and prognosis of RA. In this review, these interesting properties and some future possibilities of this diagnostic test are discussed.
format Text
id pubmed-2243253
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Humana Press Inc
record_format MEDLINE/PubMed
spelling pubmed-22432532008-02-14 Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis van Venrooij, Walther J. Zendman, Albert J. W. Clin Rev Allergy Immunol Article The literature of the last 4 years confirms that the anti-CCP2 test is a very useful marker for the early and specific diagnosis of rheumatoid arthritis (RA). The anti-CCP2 test is very specific for RA (95–99%) and has sensitivity comparable to that of the rheumatoid factor (70–75%). The antibodies can be detected very early in the disease and can be used as an indicator for the progression and prognosis of RA. In this review, these interesting properties and some future possibilities of this diagnostic test are discussed. Humana Press Inc 2007-09-18 2008-02 /pmc/articles/PMC2243253/ /pubmed/18270856 http://dx.doi.org/10.1007/s12016-007-8029-y Text en © Humana Press Inc. 2007
spellingShingle Article
van Venrooij, Walther J.
Zendman, Albert J. W.
Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
title Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
title_full Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
title_fullStr Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
title_full_unstemmed Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
title_short Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
title_sort anti-ccp2 antibodies: an overview and perspective of the diagnostic abilities of this serological marker for early rheumatoid arthritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243253/
https://www.ncbi.nlm.nih.gov/pubmed/18270856
http://dx.doi.org/10.1007/s12016-007-8029-y
work_keys_str_mv AT vanvenrooijwaltherj anticcp2antibodiesanoverviewandperspectiveofthediagnosticabilitiesofthisserologicalmarkerforearlyrheumatoidarthritis
AT zendmanalbertjw anticcp2antibodiesanoverviewandperspectiveofthediagnosticabilitiesofthisserologicalmarkerforearlyrheumatoidarthritis

Ejemplares similares